Myocardial necrosis depth prediction during extracellular photosensitization reaction of talaporfin sodium by defined index using fluorescence measurement
暂无分享,去创建一个
K. Fukuda | S. Takatsuki | M. Takahashi | A. Ito | T. Kimura | T. Arai
[1] Tsunenori Arai,et al. Nonthermal Cardiac Catheter Ablation Using Photodynamic Therapy , 2013, Circulation. Arrhythmia and electrophysiology.
[2] Tsunenori Arai,et al. Electrophysiological and histological effects on canine right atrium by photosensitization reaction under catheterization in vivo , 2013, Photonics West - Biomedical Optics.
[3] Tsunenori Arai,et al. Myocardial electrical conduction block induced by photosensitization reaction in exposed porcine hearts in vivo , 2011, Lasers in surgery and medicine.
[4] Michele T. Cooper,et al. Photodynamic therapy (PDT) using HPPH for the treatment of precancerous lesions associated with barrett's esophagus , 2011, Lasers in surgery and medicine.
[5] J. Gołąb,et al. Aminolevulinic Acid (ALA) as a Prodrug in Photodynamic Therapy of Cancer , 2011, Molecules.
[6] Tsunenori Arai,et al. Photosensitization Reaction‐Induced Acute Electrophysiological Cell Response of Rat Myocardial Cells in Short Loading Periods of Talaporfin Sodium or Porfimer Sodium , 2011, Photochemistry and photobiology.
[7] S. Kapa,et al. Correlative Anatomy for the Electrophysiologist: Ablation for Atrial Fibrillation. Part II: Regional Anatomy of the Atria and Relevance to Damage of Adjacent Structures During AF Ablation , 2010, Journal of cardiovascular electrophysiology.
[8] Tayyaba Hasan,et al. Imaging and photodynamic therapy: mechanisms, monitoring, and optimization. , 2010, Chemical reviews.
[9] M. Russo,et al. Histological substrate of human atrial fibrillation. , 2010, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
[10] Hiroki Matsuo,et al. Non-thermal ablation technology for arrhythmia therapy: acute and chronic electrical conduction block with photosensitization reaction , 2010, BiOS.
[11] Tsunenori Arai,et al. The Myocardial Electrical Blockade Induced by Photosensitization Reaction , 2010, IEEE Transactions on Biomedical Engineering.
[12] G. Hindricks,et al. Complications of Atrial Fibrillation Ablation in a High‐Volume Center in 1,000 Procedures: Still Cause for Concern? , 2009, Journal of cardiovascular electrophysiology.
[13] J. Lau,et al. Systematic Review: Comparative Effectiveness of Radiofrequency Catheter Ablation for Atrial Fibrillation , 2009, Annals of Internal Medicine.
[14] Zheng Huang,et al. Photodynamic Therapy for Treatment of Solid Tumors — Potential and Technical Challenges , 2008, Technology in cancer research & treatment.
[15] Thomas H Foster,et al. In vivo confocal fluorescence imaging of the intratumor distribution of the photosensitizer mono-L-aspartylchlorin-e6. , 2008, Neoplasia.
[16] H. Mojzisova,et al. Cellular uptake and subcellular distribution of chlorin e6 as functions of pH and interactions with membranes and lipoproteins. , 2007, Biochimica et biophysica acta.
[17] Tayyaba Hasan,et al. Photobleaching‐based Dosimetry Predicts Deposited Dose in ALA‐PpIX PDT of Rodent Esophagus , 2007, Photochemistry and photobiology.
[18] Claudio H. Sibata,et al. Experimental determination of threshold dose in photodynamic therapy in normal rat liver , 2007 .
[19] L. Lilge,et al. Implicit and explicit dosimetry in photodynamic therapy: a New paradigm , 1997, Lasers in Medical Science.
[20] James B. Bassingthwaighte,et al. Simultaneous Blood–Tissue Exchange of Oxygen, Carbon Dioxide, Bicarbonate, and Hydrogen Ion , 2006, Annals of Biomedical Engineering.
[21] Melody A. Swartz,et al. Interstitial fluid flow induces myofibroblast differentiation and collagen alignment in vitro , 2005, Journal of Cell Science.
[22] José Angel Cabrera,et al. Anatomic Relations Between the Esophagus and Left Atrium and Relevance for Ablation of Atrial Fibrillation , 2005, Circulation.
[23] Zheng Huang,et al. Studies of a vascular‐acting photosensitizer, Pd‐bacteriopheophorbide (Tookad), in normal canine prostate and spontaneous canine prostate cancer , 2005, Lasers in surgery and medicine.
[24] R. Kloner,et al. Quantitative assessment of myocardial collagen with picrosirius red staining and circularly polarized light , 1994, Basic Research in Cardiology.
[25] M. Vicente,et al. Mechanisms of porphyrinoid localization in tumors , 2002 .
[26] Robert H. Anderson,et al. Atrial structure and fibres: morphologic bases of atrial conduction. , 2002, Cardiovascular research.
[27] C. MacAulay,et al. Monitoring Photoproduct Formation and Photobleaching by Fluorescence Spectroscopy Has the Potential to Improve PDT Dosimetry with a Verteporfin-like Photosensitizer¶ , 2002, Photochemistry and photobiology.
[28] D. Sánchez-Quintana,et al. Architecture of the pulmonary veins: relevance to radiofrequency ablation , 2001, Heart.
[29] H Ector,et al. Right atrial angiographic evaluation of the posterior isthmus: relevance for ablation of typical atrial flutter. , 2000, Circulation.
[30] Robert H. Anderson,et al. Anatomy of the Left Atrium: , 1999, Journal of cardiovascular electrophysiology.
[31] Stanley B. Brown,et al. Fluorescence Photobleaching of ALA‐induced Protoporphyrin IX during Photodynamic Therapy of Normal Hairless Mouse Skin: The Effect of Light Dose and Irradiance and the Resulting Biological Effect , 1998, Photochemistry and photobiology.
[32] J. Bommer,et al. PHOTOBLEACHING OF MONO‐l‐ASPARTYL CHLORIN e6 (NPe6): A CANDIDATE SENSITIZER FOR THE PHOTODYNAMIC THERAPY OF TUMORS , 1993, Photochemistry and photobiology.
[33] J. Langberg,et al. Temperature‐Guided Radiofrequency Catheter Ablation With Very Large Distal Electrodes , 1993, Circulation.
[34] Steven L. Jacques,et al. How photobleaching affects dosimetry and fluorescence monitoring of PDT in turbid media , 1993, Photonics West - Lasers and Applications in Science and Engineering.
[35] P B Cerrito,et al. The role of microvascular damage in photodynamic therapy: the effect of treatment on vessel constriction, permeability, and leukocyte adhesion. , 1992, Cancer research.
[36] C J Gomer,et al. Metabolic properties and photosensitizing responsiveness of mono-L-aspartyl chlorin e6 in a mouse tumor model. , 1992, Cancer research.
[37] T. Hasan,et al. Role of neovasculature and vascular permeability on the tumor retention of photodynamic agents. , 1992, Cancer research.
[38] C J Gomer,et al. Tissue distribution and photosensitizing properties of mono-L-aspartyl chlorin e6 in a mouse tumor model. , 1990, Cancer research.
[39] M. Reed,et al. THE MICROVASCULAR EFFECTS OF PHOTODYNAMIC THERAPY: EVIDENCE FOR A POSSIBLE ROLE OF CYCLOOXYGENASE PRODUCTS , 1989, Photochemistry and photobiology.